柞蚕微粒子病是影响柞蚕生产,特别是蚕种生产最严重的一种传染性疾病。对该病一直沿用法国巴斯德镜检法进行防治,对控制胚种传染起到重要作用。但柞蚕放养于野外,还有食下传染这一途径无法解决。为此,我们从1990年开始进行了柞蚕微粒子病治疗药剂的研究,经过近10年对80余种药剂的筛选,研制出了治疗药剂——“蚕锈康”,其使用浓度为0.10％～0.15％,吃药叶天数为12d;最佳用药时期为3龄前。“蚕锈康”对轻症胚种传染的治疗效果达77.7％,生产防治中的防效可达85％以上。该药具有对蚕安全,体色新鲜,增强蚕体抗病性,促进生长发育,增产效果明显等特点。 Tussah microparticles disease is the production of tussah production, especially silkworm production is the most serious infectious diseases. The disease has been followed by France Pasteur microscopy control, the control of germ infection plays an important role. However, tussah stocking in the wild, there is no way to address this infection can not be solved. To this end, we started from 1990 to study the tussah microparticles disease drug treatment, after nearly 10 years of more than 80 kinds of pharmaceutical screening, developed a therapeutic agent - “silkworm rust,” its use concentration of 0.10% ~ 0.15%, the number of days of taking medicine leaves 12d; the best medication for 3 years ago. “Silkworm rust” on the treatment of mild germ infection reached 77.7%, prevention and control in the production of up to 85% control effect. The drug has the safety of silkworm, body color fresh, enhance silkworm disease resistance, and promote growth and development, yield increase effect is obvious and so on.